Cogent Biosciences Inc.
COGT | NASDAQ
$32.20
+$0.20 (+0.63%)
Sep 22, 2026, 11:56 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -17.41 | -3.36 | -2.43 | -5.12 | -4.64 | -1.87 |
PEG Ratio | 1.44 | 0.81 | -0.34 | -0.23 | 0.07 | -0.04 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | 15.81 |
PB Ratio | 8.99 | 3.36 | 1.82 | 2.66 | 1.55 | 0.53 |
P/FCF Ratio | -21.50 | -4.14 | -2.99 | -5.41 | -5.49 | -3.47 |
P/OCF Ratio | -21.62 | -4.15 | -3.05 | -5.72 | -5.66 | -3.47 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | -455.47 |
Debt / Equity Ratio | 0.40 | 0.07 | 0.07 | 0.08 | 0.01 | 0.02 |
Quick Ratio | 14.23 | 5.32 | 7.09 | 9.87 | 13.04 | 18.70 |
Current Ratio | 14.23 | 5.32 | 7.09 | 9.87 | 13.04 | 18.70 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | 0.03 |
Interest Coverage | -108.87 | n/a | n/a | -37.06 | n/a | n/a |
Return on Equity | -51.69% | -99.83% | -74.63% | -54.84% | -33.74% | -31.88% |
Return on Assets | -35.08% | -78.03% | -61.39% | -46.62% | -31.14% | -29.81% |
Return on Invested Capital | -38.09% | -100.80% | -75.23% | -53.68% | -34.76% | -34.27% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | -227% |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | -950.43% |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | -950.43% |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | -1.04K% |
FCF Margin | n/a | n/a | n/a | n/a | n/a | -455.47% |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | -439.19% |
Add to Watchlist
Select watchlists to add or remove COGT